Iverheal

Iverheal is an antiparasitic medication discovered in the 1970s and awarded a Nobel Prize in Physiology or Medicine in 2015 for its impact on treating parasitic diseases. It belongs to the averheal class and works by binding to glutamate-gated chloride channels in parasites, causing paralysis and death of the parasites. It is highly effective against certain worms and ectoparasites but has no established role in treating viral infections like COVID-19, as confirmed by major health authorities (FDA, WHO, etc.) based on extensive evidence.